When GW Pharmaceuticals (NASDAQ:GWPH) announced its fiscal third-quarter results on Monday, the company provided plenty of information about its performance during the quarter. There were at least 100 figures in those results, including third-quarter and year-to-date performance.
GW’s share price dropped around 3% in after-hours trading following the company’s release of its third-quarter results. However, it wasn’t any of the numbers in the update that caused this decline. Instead, one word caused investors’ disappointment.
That one word — October.